Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
about
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressorInteraction of the HPV E7 proteins with the pCAF acetyltransferaseActivation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2AEffects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complexModulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoproteinRegulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 OncoproteinsHuman Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical CancerFunctional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical SitesInteraction between the HPV E7 oncoprotein and the transcriptional coactivator p300Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein.A geminivirus replication protein interacts with a protein kinase and a motor protein that display different expression patterns during plant development and infection.Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARFRetinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cellsCritical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesisDestabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein.Human papilloma virus DNA exposure and embryo survival is stage-specific.Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical CancersThe epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair.Evolution of human papillomavirus carcinogenicity.Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesIdentification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells.Different Isoforms of HPV-16 E7 Protein are Present in Cytoplasm and Nucleus.Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sitesThe papillomavirus E7 proteins.The biological properties of E6 and E7 oncoproteins from human papillomaviruses.Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein.Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.The human papillomavirus E7 oncoprotein as a regulator of transcription.The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1.Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
P2860
Q24292803-F74B7AA2-9203-44F7-892B-34704E26B376Q24305508-FC484DBE-9374-4FB6-A2E3-654238DAF662Q24310210-9573092A-D437-4E86-B84B-6CCF712D503DQ24532787-9BE54A45-3DBC-49E6-BF7C-1B36A48393E8Q24676090-25AC0673-6127-4AA1-856C-716B8A1C670FQ26795741-478F1C73-09CF-4CC7-88BC-C27DE0AF746AQ26799484-C996A046-CC0D-4A0A-AC01-D89A805E178CQ28078631-1144427D-85B3-488B-9F06-1E6E5D29A320Q28566098-817B50AE-C36F-4755-B61C-E95EBFB4AEE6Q31032936-9D917968-F7BF-4205-86D2-EAF944F09992Q31103016-F34CF6BD-B415-4A38-A8A0-62C4130EB513Q33292114-0BBA1F0D-8CD5-43A9-B66D-EA557B860875Q33292435-DA1176DE-5E2E-4BCD-9073-C5B564722598Q33567807-FFAC6F9D-4F98-4AA9-9788-16CA56626D5BQ33795204-15744F9E-E06A-427C-A83B-3991B16D5E32Q33805184-8E33C399-39F4-4C7B-BD2E-D05E565D551DQ33844017-10F9AC04-DA78-4DE2-979B-368D3845C13BQ33930412-3C0DF315-FC41-42A1-9798-5D43F31B714AQ34387292-28210550-E4E4-448C-940B-EA637309A6D3Q34411810-0B014DD2-40C8-4D64-AA1B-CC341B15CB5CQ34733433-44187B87-057F-493D-91DA-6A86AFE66362Q34758890-9772621A-ECF1-46F2-B59F-82F7FA46E1B3Q36423231-3414A777-1EB2-4BF3-81FE-0CE7BB66E799Q36652548-9F6F9096-ED8F-4CE1-A787-B0F77CF6F4E2Q36717732-65628EC8-8F33-4B4D-9FFD-9F03A774F929Q36780283-38597C53-E67C-49BB-8D2F-24B5BBB5E9A5Q36949283-EB4FA8D3-2D02-40A7-BFF0-4BBEC058BD0EQ36989890-F48760CB-7489-4047-AA1A-CE0C6C5388FBQ37106878-E917136E-1C05-460A-93C9-53111A2230B9Q37110741-0F0A1CF0-62DE-4221-A6CA-5AED39A4503BQ37183621-087562E1-53B3-457F-A15E-ED4E7259C027Q37194934-B0BB46C7-7710-47F0-ABE9-30FAB68C3307Q37198662-BBAE924F-CFB1-4F0C-809A-BF3681A5E0C3Q37617163-683CC0A0-E4D5-479F-86F5-7E48D0BB52B4Q38313989-76017729-9713-466D-AACA-21167A9AAE52Q38859115-D317F564-E42C-40D6-AB56-EA03810DA971Q39000409-BB9F4F15-B8F1-4EDC-8380-4712211A8E63Q39440454-1ECD15A6-B86E-4597-A5C1-C82B56E75877Q39455066-DD240146-A59D-4A7C-9520-8879816A74E5Q40008977-2FB6D89E-B2FC-4C1A-8835-033F35CEAE5F
P2860
Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@en
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@nl
type
label
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@en
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@nl
prefLabel
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@en
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@nl
P2093
P1476
Human papillomavirus type 16 E ...... s to E7 transforming activity.
@en
P2093
P304
P356
10.1099/0022-1317-78-10-2607
P407
P478
78 ( Pt 10)
P577
1997-10-01T00:00:00Z